These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
636 related articles for article (PubMed ID: 26369898)
21. Incidence and outcome of pauci-immune rapidly progressive glomerulonephritis in Wessex, UK: a 10-year retrospective study. Hedger N; Stevens J; Drey N; Walker S; Roderick P Nephrol Dial Transplant; 2000 Oct; 15(10):1593-9. PubMed ID: 11007827 [TBL] [Abstract][Full Text] [Related]
22. Antineutrophil cytoplasmic antibody-negative pauci-immune crescentic glomerulonephritis associated with rheumatoid arthritis: An unusual case report. Hsieh HS; Chang CF; Yang AH; Kuo HL; Yang WC; Lin CC Nephrology (Carlton); 2003 Oct; 8(5):243-7. PubMed ID: 15012711 [TBL] [Abstract][Full Text] [Related]
23. C3 deposits worsens the prognosis in type iii extracapillary glomerulonephritis. Sánchez-Agesta Martínez M; Rabasco Ruiz C; Sánchez Sánchez R; Ortega Salas R; López Andreu M; Aljama García P; Espinosa Hernández M Nefrologia (Engl Ed); 2018; 38(2):213-219. PubMed ID: 28988671 [TBL] [Abstract][Full Text] [Related]
24. Coexistence of anti-GBM antibodies and MPO-ANCA in a patient with systemic vasculitis and crescentic glomerulonephritis. Fernandes P; Lopes JA; Correia L; Gonçalves S; Jorge S Nefrologia; 2010; 30(6):709-10. PubMed ID: 21113229 [No Abstract] [Full Text] [Related]
30. Histologic and immunohistologic study and clinical presentation of ANCA-associated glomerulonephritis with correlation to ANCA antigen specificity. Vizjak A; Rott T; Koselj-Kajtna M; Rozman B; Kaplan-Pavlovcic S; Ferluga D Am J Kidney Dis; 2003 Mar; 41(3):539-49. PubMed ID: 12612976 [TBL] [Abstract][Full Text] [Related]
31. Glomerular C3d as a novel prognostic marker for renal vasculitis. Villacorta J; Diaz-Crespo F; Acevedo M; Guerrero C; Campos-Martin Y; García-Díaz E; Mollejo M; Fernandez-Juarez G Hum Pathol; 2016 Oct; 56():31-9. PubMed ID: 27257040 [TBL] [Abstract][Full Text] [Related]
32. ANCA positive crescentic glomerulonephritis outcome in a Central East European cohort: a retrospective study. Andreiana I; Stancu S; Avram A; Taran L; Mircescu G BMC Nephrol; 2015 Jun; 16():90. PubMed ID: 26123651 [TBL] [Abstract][Full Text] [Related]
35. Characteristics and outcome of crescentic glomerulonephritis in patients with both antineutrophil cytoplasmic antibody and anti-glomerular basement membrane antibody. Srivastava A; Rao GK; Segal PE; Shah M; Geetha D Clin Rheumatol; 2013 Sep; 32(9):1317-22. PubMed ID: 23624587 [TBL] [Abstract][Full Text] [Related]
36. Dual anti-neutrophil cytoplasmic antibody-related pauci-immune crescentic glomerulonephritis in a patient with Sjögren's syndrome. Lee IH; Kim SK; Kim MK Rheumatol Int; 2016 Sep; 36(9):1327-34. PubMed ID: 27384449 [TBL] [Abstract][Full Text] [Related]
37. Pauci-immune extracapillary glomerulonephritis and atheromatous embolization. Aviles B; Ubeda I; Blanco J; Barrientos A Am J Kidney Dis; 2002 Oct; 40(4):847-51. PubMed ID: 12324923 [TBL] [Abstract][Full Text] [Related]